Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this observational study is to evaluate the effectiveness of Magnetoencephalography (MEG) in the preoperative assessment of children with refractory epilepsy, particularly in identifying the seizure focus, and to compare it with the gold standard methods of Stereo-electroencephalography (SEEG) and Electrocorticography (ECoG). The main questions this study aims to answer are:
- 1.How consistent is MEG with SEEG/ECoG in locating the epileptic focus in children with refractory epilepsy?
- 2.What is the clinical efficacy of MEG in identifying epileptic foci?
- 3.Be divided into 2 groups: the case group and the control group. Participants in the case group will undergo both MEG and SEEG/ECoG for preoperative assessment, while patients in the control group will undergo only SEEG/ECoG before surgery.
- 4.Be followed up at 1, 3, 6, and 12 months after surgery to assess seizure control, neurological function, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2024
CompletedFirst Submitted
Initial submission to the registry
February 26, 2025
CompletedFirst Posted
Study publicly available on registry
July 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
July 14, 2025
July 1, 2025
3.2 years
February 26, 2025
July 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Agreement in Epileptogenic Zone Localization Between Magnetoencephalography (MEG) and Stereoelectroencephalography/Electrocorticography (SEEG/ECoG) (Kappa Coefficient)
This outcome measures the agreement between preoperative MEG and SEEG/ECoG (gold standard) in localizing the epileptogenic zone. Consistency will be quantified using Cohen's Kappa coefficient (κ) with 95% confidence intervals. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) will be calculated. Data aggregation will compare MEG-derived localization (categorized by brain regions, e.g., temporal lobe, frontal lobe) with intraoperative SEEG/ECoG findings. Statistical analysis will be performed using SPSS 27.0.
From enrollment to 12 months after surgery.
Study Arms (2)
Case
Participants in the case group will undergo both MEG and SEEG/ECoG for preoperative assessment.
Control
Patients in the control group will undergo only SEEG/ECoG before surgery.
Interventions
Use Magnetoencephalography and Stereo-electroencephalography/Electrocorticography in the preoperative assessment of children with drug-resistant epilepsy, particularly in identifying the seizure focus.
Use Stereo-electroencephalography/Electrocorticography in the preoperative assessment of children with drug-resistant epilepsy, particularly in identifying the seizure focus.
Eligibility Criteria
Pediatric patients of Guangzhou Women and Children's Medical Center
You may qualify if:
- Age range: 3-18 years old;
- Clinically diagnosed with refractory epilepsy;
- Capable of cooperating with magnetoencephalography evaluation and recording.
You may not qualify if:
- Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination.
- Patients using drugs that affect central nervous system function;
- Patients who are not suitable for surgical procedures;
- Patients with progressive neurological disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangzhou Women and Children's medical center
Guangzhou, Guangdong, 511399, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2025
First Posted
July 14, 2025
Study Start
November 5, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
July 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share